ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
6111 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter ETH Entrepreneurship
26/06/2021 – Xenotheka
... 26, 2021 0 12 33 _English Language Philosophy Ahmed, What’s the Use In What’s the Use? Sara Ahmed ... & British Isles 26 Enlightenment Library 127 Evolution 4 Fashion 5 Feminism 19 Film Festival 1 France 45 ... 26, 2021 0 12 33 _English Language Philosophy Ahmed, What’s the Use In What’s the Use? Sara Ahmed ... & British Isles 26 Enlightenment Library 127 Evolution 4 Fashion 5 Feminism 19 Film Festival 1 France 45 ... 26/06/2021 – Xenotheka ...
26/09/2019 – Xenotheka
... & British Isles 26 Enlightenment Library 127 Evolution 4 Fashion 5 Feminism 19 Film Festival 1 France 45 ... Italy 79 Landscape Architecture 8 LGBT 1 Libraries 0 Linguistics 2 Literary Criticism 6 Literary Theory ... & British Isles 26 Enlightenment Library 127 Evolution 4 Fashion 5 Feminism 19 Film Festival 1 France 45 ... Italy 79 Landscape Architecture 8 LGBT 1 Libraries 0 Linguistics 2 Literary Criticism 6 Literary Theory ... 26/09/2019 – Xenotheka ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
31004 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter Somagenetix
sfuers%2C+0+Editorial_Greco+%26+Lobinger+OA.pdf";filename*=UTF-8'
... erstattung von ARD, ZDF, Sat. 1 und RTL», Benjamin P. Lange, Aylin Bayirli and Frank Schwab propose an ... Studies in Communication Sciences 20.2 ( 2020), pp. 129–131 Editorial Sara Greco*, Università della ... sfuers%2C+ 0+Editorial_Greco+% 26+Lobinger+OA.pdf";filename*=UTF-8' ... erstattung von ARD, ZDF, Sat. 1 und RTL», Benjamin P. Lange, Aylin Bayirli and Frank Schwab propose an ... sfuers%2C+ 0+Editorial_Greco+% 26+Lobinger+OA.pdf";filename*=UTF-8' ...
1
... 0 1 9 Session 3: Biodiversity and agricultural sustainability 9.00-9.30 Claire Chenu* Managing ... ). Preliminary Program Note: *indicates keynote speaker. T h u rs d a y , 1 4 th N o v e m b e r, 2 0 1 9 Session ... 0 1 9 Session 3: Biodiversity and agricultural sustainability 9.00-9.30 Claire Chenu* Managing ... ). Preliminary Program Note: *indicates keynote speaker. T h u rs d a y , 1 4 th N o v e m b e r, 2 0 1 9 Session ... 1 ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
17844 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter University of Zurich
S10064-0 263..268
... occurrence (or about 2 in 3), of 26% (or about 1 in 4) for a 100-year return period and of 10% (or about 1 in ... > 1 m Settlement – Presence of dolines or sinkholes – Table 3 Probability of landsliding as defined ... occurrence (or about 2 in 3), of 26% (or about 1 in 4) for a 100-year return period and of 10% (or about 1 in ... > 1 m Settlement – Presence of dolines or sinkholes – Table 3 Probability of landsliding as defined ... S10064- 0 263..268 ...
0/1-Hour Triage Algorithm for Myocardial Infarction in Patients Wit...
... Copy Abstract BACKGROUND The European Society of Cardiology recommends a 0/ 1-hour algorithm for ... elevation myocardial infarction, concern has been raised regarding the performance of the 0/ 1-hour algorithm ... 0/ 1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction - Zurich ... 0/ 1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction - Zurich ... 0/ 1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction - Zurich ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
704 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter University Hospital Zurich, Research and Education Office
Table 1
... material as in Fig. 1. Weeks 18 20 24 28 32 36 40 -2.5 0 2.5 5.0 BDecf mmol/l n=58 Umbicial vein Fig. 3 ... 24 26 28 30 32 34 36 38 40 7.25 7.30 7.35 7.40 7.45 7.50 pH n=59 Umbicial vein Fig. 1. pH in the ... material as in Fig. 1. Weeks 18 20 24 28 32 36 40 -2.5 0 2.5 5.0 BDecf mmol/l n=58 Umbicial vein Fig. 3 ... 24 26 28 30 32 34 36 38 40 7.25 7.30 7.35 7.40 7.45 7.50 pH n=59 Umbicial vein Fig. 1. pH in the ... Table 1 ...
Slide 1
... institutions. Table 1 Patient characteristics Mean DAH for all four cantons was 26 days. In the multivariable ... Slide 1 A retrospective database study investigating days spent in acute care hospitals during the ... institutions. Table 1 Patient characteristics Mean DAH for all four cantons was 26 days. In the multivariable ... Slide 1 ... Slide 1 ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
106 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter InSphero AG
Slide 1
... 4 h 7 2 h 1 44 h IC 5 0 = 8 3 . 3 M IC 5 0 = 4 7 .9 M IC 5 0 = 2 5 . 0 M 0 . 1 1 1 0 1 0 0 0 5 0 1 0 ... in culture 4 7 1 1 1 4 1 8 2 1 4 7 1 1 1 4 1 8 2 1 0 1 0 2 0 3 0 4 0 5 0 6 0 A T P ( p m o l/ M T ) T ... 4 h 7 2 h 1 44 h IC 5 0 = 8 3 . 3 M IC 5 0 = 4 7 .9 M IC 5 0 = 2 5 . 0 M 0 . 1 1 1 0 1 0 0 0 5 0 1 0 ... in culture 4 7 1 1 1 4 1 8 2 1 4 7 1 1 1 4 1 8 2 1 0 1 0 2 0 3 0 4 0 5 0 6 0 A T P ( p m o l/ M T ) T ... Slide 1 ...
Folie 1
... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Folie 1 ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
245 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter Blutspende SRK Zürich
Folie 1
... DAU proposita (e.g. DAU- 3/RHd, or homozygous non-DAU- 0/non-DAU- 0) still require RhD negative blood in ... common SNPs of non-DAU- 0 alleles in exon 5, 697G>C/A (DAU-4, -5), in exon 6, 835G>A (DAU- 3, -7) and in ... DAU proposita (e.g. DAU- 3/RHd, or homozygous non-DAU- 0/non-DAU- 0) still require RhD negative blood in ... common SNPs of non-DAU- 0 alleles in exon 5, 697G>C/A (DAU-4, -5), in exon 6, 835G>A (DAU- 3, -7) and in ... Folie 1 ...
Folie 1
... on day 0 (54% of source plasma) and 13.9-18.3 h if frozen on day 1 (Fig. 3). Range of time for ... (day 1). Earlier donations were frozen on day 0. Figure 3: Data Source Plasma Day 0 Day 1 Figure 4 ... on day 0 (54% of source plasma) and 13.9-18.3 h if frozen on day 1 (Fig. 3). Range of time for ... (day 1). Earlier donations were frozen on day 0. Figure 3: Data Source Plasma Day 0 Day 1 Figure 4 ... Folie 1 ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
616 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter Roche Glycart AG
Qualitative Parainfluenza 1-4 Test
... parainfluenza 1, parainfluenza 2, parainfluenza 3, and parainfluenza 4. Flexible syndromic testing Test what ... discrimination of human Parainfluenza virus serotypes 1, 2, 3, and 4 (HPIV1-4). This test is intended to be used ... viruses parainfluenza 1, parainfluenza 2, parainfluenza 3, and parainfluenza 4. Related information ... discrimination of human Parainfluenza virus serotypes 1, 2, 3, and 4 (HPIV1-4). This test is intended to be used ... Qualitative Parainfluenza 1-4 Test ...
Tina-quant® HbA1c Gen. 3
... deaths, has become a worldwide health topic. 1 In 2019, more than one in 10 adults is living with diabetes ... . Current ADA guidelines recommend the HbA1c tests for use in diagnosing type 2 diabetes and prediabetes. 3 ... Tina-quant® HbA1c Gen. 3 ... https://diagnostics.roche.com/se/sv/products/params/tina-quant-hba1c-gen- 3.html ... Tina-quant® HbA1c Gen. 3 ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
151 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter Bio-Technopark Schlieren-Zürich
Biologics Drug Product Development – Virtual Road Show by Lonza, Ma...
... Biologics Drug Product Development – Virtual Road Show by Lonza, Mar 15–19, 2021 and Mar 22– 26 ... ? How to comply with MABEL and the new Annex 1? We kindly invite you to meet our drug product experts ... November » Mo Di Mi Do Fr Sa So 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... Biologics Drug Product Development – Virtual Road Show by Lonza, Mar 15–19, 2021 and Mar 22– 26 ... Biologics Drug Product Development – Virtual Road Show by Lonza, Mar 15–19, 2021 and Mar 22– 26 ...
Biologics Drug Product Development – Virtual Road Show by Lonza, Ma...
... Biologics Drug Product Development – Virtual Road Show by Lonza, Mar 15–19, 2021 and Mar 22– 26 ... ? How to comply with MABEL and the new Annex 1? We kindly invite you to meet our drug product experts ... Mi Do Fr Sa So 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... Biologics Drug Product Development – Virtual Road Show by Lonza, Mar 15–19, 2021 and Mar 22– 26 ... Biologics Drug Product Development – Virtual Road Show by Lonza, Mar 15–19, 2021 and Mar 22– 26 ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
55 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter Neurimmune Therapeutics AG
Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's...
... February 19, 2017 BIIB076 Moves into Phase 1 for Alzheimer's Disease BIIB076 has moved into phase 1 ... BIIB076 Moves into Phase 1 for Alzheimer's Disease January 26, 2017 | Company News Neurimmune's joint ... Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's Disease ... Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's Disease ...
Neurimmune - 21.03.2019: Biogen and Eisai to discontinue Phase 3 EN...
... March 21, 2019 Biogen and Eisai to discontinue Phase 3 ENGAGE and EMERGE trials of Aducanumab ... to discontinue Phase 3 ENGAGE and EMERGE trials of Aducanumab in Alzheimer’s disease. Neurimmune has ... Aducanumab February 19, 2017 | Company News BIIB076 Moves into Phase 1 for Alzheimer's Disease January 26 ... 27, 2020 | Press Release Neurimmune Announces the Initiation of a Phase 1 Study of NI006 for the ... Neurimmune - 21.03.2019: Biogen and Eisai to discontinue Phase 3 ENGAGE and EMERGE trials of ...
Kowa Pharmaceutical Europe AG
https://kowapharmaceuticals.eu/
8952 Schlieren, Zürcherstrasse 39D
Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, Ltd., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities. Kowa are committed to improving health standards in Europe and globally.
Kowa Pharmaceutical Europe AG
Zürcherstrasse 39D
8952 Schlieren
9 Ergebnisse für "怎么查酒店开房信息- 查询微信1 26 0 -网上能查跟谁开房的信息吗-酒店开房如何避免查信息-怎么样可以查开房信息- 查询微信2020 3 1 -开房信息被公安查uS" unter Kowa Pharmaceutical Europe AG
Initiation of Phase 3 clinical study in the United States Indicatio...
... dystrophy [Development code: K-321] 1 August 26, 2022 Dear all Kowa Company, Ltd. Kowa Company, Ltd ... Initiation of Phase 3 clinical study in the United States Indication for Fuchs endothelial corneal ... dystrophy [Development code: K-321] 1 August 26, 2022 Dear all Kowa Company, Ltd. Kowa Company, Ltd ... August 26, 2022 Initiation of Phase 3 clinical study in the United States Indication for Fuchs ... Initiation of Phase 3 clinical study in the United States Indication for Fuchs endothelial corneal ...
Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01-3/DC
... pitavastatin for 1 year with 12 patients receiving pitavastatin for 2.5 years and 2 patients for 3 years. Less ... received treatment with pitavastatin 1, 2, or 4mg for 2 years, were continued on treatment for a further 3 ... pitavastatin for 1 year with 12 patients receiving pitavastatin for 2.5 years and 2 patients for 3 years. Less ... received treatment with pitavastatin 1, 2, or 4mg for 2 years, were continued on treatment for a further 3 ... Pitavastatin 1mg, 2mg & 4mg film-coated tablets UK/H/1555-8/01- 3/DC ...
